ABY-035 in the Treatment of Subjects With Ankylosing Spondylitis

PHASE2TerminatedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

August 24, 2021

Primary Completion Date

July 11, 2022

Study Completion Date

August 30, 2022

Conditions
Ankylosing Spondylitis
Interventions
DRUG

ABY-035

ABY-035 Solution for injection

DRUG

Placebo

Normal Saline for injection

Trial Locations (47)

16635

Altoona Center for Clinical Research, Duncansville

20902

The Center for Rheumatology and Bone Research, Wheaton

21740

Klein & Associates, M.D., P.A., Hagerstown

27704

M3 Emerging Medical Research, LLC, Durham

33180

Arthritis and Rheumatic Disease Specialties, Aventura

34293

Drucker Sarasota Arthritis Research Center, Sarasota

43551

Clinical Research Source, Inc., Perrysburg

60076

Clinic of Robert Hozman, MD / Clinical Investigation Specialists,, Skokie

60195

Greater Chicago Specialty Physicians/ Clinical Investigation Specialists, Inc., Schaumburg

75240

HRMD Research, Dallas

85306

Arizona Arthritis & Rheumatology Research, PLLC, Glendale

91303

Hope Clinical Research, Canoga Park

92260

Desert Medical Advances, Palm Desert

92648

Newport Huntington Medical Group, Huntington Beach

98122

Seattle Rheumatology Associates, Seattle

Unknown

The First Affiliated Hospital of Bengbu Medical College, Bengbu

Anhui Provincial Hospital, Hefei

Beijing Chao-Yang Hospital,Capital Medical University, Beijing

Sun Yat-Sen Memorial Hospital Sun Yat-Sen University, Guangzhou

Shenzhen People's Hospital, Shenzhen

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

Tong Ji Hospital TongJi Medical Colleague of HUST, Wuhan

Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Zhuzhou

The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and TechNology, Baotou

The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing

The First Affiliated Hospital of Soochow University, Suzhou

The First Affiliated Hospital of Nanchang University, Nanchang

The First Hospital of Jilin University, Changchun

Linyi People's Hospital, Linyi

Changhai Hospital of Shanghai, Shanghai

Shanghai Changzheng Hospital, Shanghai

West China Hospital of Sichuan University, Chengdu

Kaohsiung Chang Gung Memorial Hospital ,Chang Gung Medical Foundation, Gaoxiong

Kaohsiung Veterans General Hospital, Gaoxiong

National Taiwan University Hospital (NTUH), Taibei

Tri-Service General Hospital, Taibei

China Medical University Hospital (CMUH), Taizhong

Chung Shan Medical University Hospital (CSMHU), Taizhong

The Affiliated Hospital of The Affiliated Hospital of Inner Mongolia Medical University Medical University, Hohhot

Tianjin Medical University General Hospital, Tianjin

Chonnam National University Hospital, Gwangju

Ajou University Hospital, Gyeonggi-do

Bundang Seoul National University Hospital, Gyeonggi-do

Inha University Hospital, Incheon

Hanyang University Seoul Hospital, Seoul

Kyunghee University Hospital, Seoul

SNU Boramae Medical Center, Seoul

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Affibody

INDUSTRY

lead

Inmagene LLC

INDUSTRY

NCT04795141 - ABY-035 in the Treatment of Subjects With Ankylosing Spondylitis | Biotech Hunter | Biotech Hunter